← NU SKIN ENTERPRISES, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.2b |
$2.3b
+3.23%
|
$2.7b
+17.55%
|
$2.4b
-9.65%
|
$2.6b
+6.67%
|
$2.7b
+4.41%
|
$2.2b
-17.44%
|
$2.0b
-11.53%
|
$1.7b
-12.04%
|
$1.5b
-14.26%
|
$1.4b
-2.95%
|
|
| Cost of Revenue | $500.5m |
$502.1m
+0.32%
|
$634.1m
+26.30%
|
$581.4m
-8.31%
|
$658.0m
+13.18%
|
$675.2m
+2.61%
|
$630.9m
-6.56%
|
$611.9m
-3.02%
|
$550.2m
-10.07%
|
$453.8m
-17.53%
|
$442.4m
-2.51%
|
|
| Gross Profit | $1.7b |
$1.8b
+4.08%
|
$2.0b
+15.07%
|
$1.8b
-10.07%
|
$1.9b
+4.62%
|
$2.0b
+5.02%
|
$1.6b
-21.07%
|
$1.4b
-14.89%
|
$1.2b
-12.93%
|
$1.0b
-12.73%
|
$998.9m
-3.15%
|
|
| Research and Development Expense | $24.3m | $22.0m | $23.0m | $30.1m | $23.3m | $27.2m | $23.3m | $22.6m | $13.0m | $10.8m | — | |
| General and Administrative Expense | $554.2m | $564.5m | $662.3m | $616.0m | $646.8m | $666.4m | $555.8m | $546.9m | $479.0m | $432.1m | $417.5m | |
| Amortization of Intangible Assets | $8.4m | $8.1m | $18.3m | $13.4m | $9.8m | $11.7m | $9.7m | $11.9m | $12.3m | $7.1m | — | |
| Restructuring Costs | — | — | $15.5m | — | — | — | — | — | — | — | — | |
| Operating Expenses | $1.5b | $1.5b | $1.8b | $1.6b | $1.7b | $1.8b | $1.5b | $1.3b | $1.3b | $965.6m | $917.4m | |
| Operating Income (Loss) | $231.1m |
$274.5m
+18.77%
|
$240.9m
-12.25%
|
$267.4m
+11.03%
|
$257.6m
-3.69%
|
$234.0m
-9.15%
|
$110.8m
-52.63%
|
$48.3m
-56.46%
|
($151.6m)
-414.05%
|
$65.8m
+143.38%
|
$81.5m
+23.98%
|
|
| Interest Expense | $15.6m | $22.2m | $21.8m | $19.2m | $13.1m | $11.0m | $13.5m | $25.6m | — | — | $14.9m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $26.4m | $13.9m | $14.9m | |
| Income (Loss) from Equity Method Investments | — | $1.0m | $456k | $0 | $0 | — | — | — | — | — | — | |
| Nonoperating Income (Expense) | ($18.3m) | ($8.9m) | ($21.2m) | ($12.3m) | ($1.3m) | ($1.5m) | ($21.9m) | ($21.7m) | $2.9m | ($31.8m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($19.1m) | $1.1m | ($67.1m) | $24.2m | $71.1m | $45.4m | $24.4m | ($37.2m) | ($237.7m) | $114.2m | $64.2m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $212.8m | $265.6m | $219.7m | $255.2m | $256.2m | $232.5m | $89.0m | $26.6m | ($175.1m) | $196.2m | $64.2m | |
| Current Income Tax Expense (Benefit) | $69.9m | $92.1m | $117.0m | $81.9m | $78.7m | $78.9m | $35.6m | $33.1m | $27.0m | $36.0m | $9.7m | |
| Income Tax Expense (Benefit) | $69.8m | $136.1m | $97.8m | $81.6m | $64.9m | $85.2m | ($15.8m) | $18.0m | ($28.5m) | $36.0m | $9.7m | |
| Net Income (Loss) Attributable to Parent | $143.1m |
$129.4m
-9.54%
|
$121.9m
-5.83%
|
$173.6m
+42.39%
|
$191.4m
+10.26%
|
$147.3m
-23.04%
|
$104.8m
-28.85%
|
$8.6m
-91.80%
|
($146.6m)
-1805.57%
|
$160.2m
+209.28%
|
$54.5m
-65.97%
|
|
| Earnings Per Share, Basic | $2.58 | $2.45 | $2.21 | $3.13 | $3.66 | $2.93 | $2.10 | $0.17 | ($2.95) | $3.25 | $1.13 | |
| Earnings Per Share, Diluted | $2.55 | $2.36 | $2.16 | $3.10 | $3.63 | $2.86 | $2.07 | $0.17 | ($2.95) | $3.18 | $1.08 | |
| Weighted Average Number of Shares Outstanding, Basic | 55.4m | 52.8m | 55.2m | 55.5m | 52.3m | 50.2m | 50.0m | 49.7m | 49.7m | 49.3m | 48.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | 56.1m | 54.9m | 56.5m | 55.9m | 52.8m | 51.4m | 50.5m | 49.9m | 49.7m | 50.3m | 50.1m | |
| Additional Financial Items | ||||||||||||
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | — | — | $28.1m | — | |
| Goodwill, Impairment Loss | $0 | — | — | — | — | — | $0 | — | — | — | — | |
| Selling Expense | $922.1m | $938.0m | $1.1b | $955.6m | $1.0b | $1.1b | $879.6m | $742.4m | $652.0m | $508.4m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.